Liver Fibrosis Models: Bridging Preclinical Efficacy with Human Trial Success
Time: 8:30 am
day: Day One
Details:
- Exploring the core disconnect between preclinical liver fibrosis models and clinical trial settings
- Enhancing translational relevance through refined animal models, optimized preclinical endpoints, and robust study designs
- Evaluating drug candidate associations with disease severity, progression, and clinical outcomes